Neuroscience Territory Account Specialist

Neurocrine Biosciences; Arizona; On-site; USD 123,000 - 168,000; Full time

Benefits offered by this job

Retirement savings plan

Health benefits

Job summary

Neurocrine Biosciences in the United States (Arizona territory) seeks a driven sales professional to promote our neuroscience and related products. You will manage physician relationships, educate external customers, and represent Neurocrine brand indications across assigned accounts, coordinating with cross-functional partners to maximize patient access and outcomes.

The role emphasizes field presence Monday through Friday with occasional events, and requires adherence to FDA guidelines and

Qualifications

• 4+ years in commercial pharma/biotech with 3+ years in specialty pharma or neurology sales.
• BS/BA in science or related field required; advanced degree preferred.
• Experience with Salesforce, Oracle, SAP, or Veeva expected.
• Strong knowledge of healthcare regulatory environments.

Responsibilities

• Drive product acceptance and growth through education and account management.
• Execute territory sales strategies through in-person and virtual communications.
• Build and maintain relationships with healthcare providers and clinical staff.
• Collaborate with internal teams including marketing and medical affairs.

Skills

Territory management

Account management

Communication

Strategic planning

Relationship building

Education

BS/BA in science or related field

Master's in science

Tools

Salesforce

Oracle

SAP

Veeva

Job description

Neurocrine Biosciences in the United States (Arizona territory) seeks a driven sales professional to promote our neuroscience and related products. You will manage physician relationships, educate external customers, and represent Neurocrine brand indications across assigned accounts, coordinating with cross-functional partners to maximize patient access and outcomes.

The role emphasizes field presence Monday through Friday with occasional events, and requires adherence to FDA guidelines and